月旦知識庫
 
  1. 熱門:
 
首頁 臺灣期刊   法律   公行政治   醫事相關   財經   社會學   教育   其他 大陸期刊   核心   重要期刊 DOI文章
NTUT Journal of Intellectual Property Law and Management 本站僅提供期刊文獻檢索。
  【月旦知識庫】是否收錄該篇全文,敬請【登入】查詢為準。
最新【購點活動】


篇名
"Patent Term Extension (PTE) Regime in Australia: Amendments and Analysis of Granted, Pending, and Refused PTE Applications"
並列篇名
"Patent Term Extension (PTE) Regime in Australia: Amendments and Analysis of Granted, Pending, and Refused PTE Applications"
作者 Mayur KardileArchna RoyManthan Janodia
英文摘要
"Patents are governed by the Patent Act 1990 in Australia. The adoption of Trade-Related Aspect of Intellectual Property Rights (TRIPS) agreement in 1995, raised the standard patent term from 16 to 20 years in Australia. For pharmaceutical innovators, 20-year term may found to be insufficient to recoup the investment in research and development (R&D), because a substantial time is required for regulatory review process before approval of the pharmaceutical product and thus, start of its actual marketing. To address this concern, the possibility of extension of the patent term beyond 20 years was introduced in Australia in 1998 by amending the Patent Act 1990. This patent term extension provision came into effect on 27 January 1999. No separate or sui generis right came into existence; rather, the duration of the patent was increased by a particular period of time, referred to as ‘Patent Term Extension(s)’ (PTE) in Australia and United States of America (USA), ‘Certificate of Supplementary Protection’ (CSP) in Canada, and ‘Supplementary Protection Certificate’ (SPC) in Europe. Since the implementation of PTE regime in Australia, a few changes took effect. This article provides an in-depth evaluation of PTE in Australia and other relevant changes. It also covers comparative analysis of number of PTE applications granted, pending, refused, and withdrawn in Australia. It was found that during these years, about 92% applications were awarded PTEs, 4% were refused and the remaining applications are awaiting decision. About 70% PTE applications cited product patents, while about 31% applications cited combination/composition patents and remaining 8% applications cited method of use patents. About 57% of granted PTEs received an extension of more than 4 years to 5 years. This article also provides analysis of type of patents referred in the PTE applications, the applicants and term of granted PTEs. Comprehensive summary of Federal Court of Australia and Full Federal Court of Australia cases is provided. These cases are related to challenges filed by PTE applicants over refusal of their applications, revocation of granted patents and challenges to the validity of granted PTE by the Commissioner of Patents, Intellectual Property Office, IP Australia, and these cases are providing directions to the Commissioner of Patents and has potential to act as precedence for future decisions on PTE. Basis analysis of available PTE data in Australia, this article also provides some valuable suggestions to the PTE applicants."
起訖頁 61-85
關鍵詞 Australian Register of Therapeutic GoodsFederal Court of AustraliaPatent Term ExtensionPharmaceutical SubstanceTherapeutic Goods Administration
刊名 NTUT Journal of Intellectual Property Law and Management  
期數 202112 (10:2期)
出版單位 國立臺北科技大學智慧財產權研究所
該期刊-上一篇 Trade Secrets Protection on Telecommunication Service Industries in Indonesian Law and Intellectual Property Perspective
該期刊-下一篇 The Problem of Copyright Protection for Machine Learning Databases: A Comparative Study
 

新書閱讀



最新影音


優惠活動




讀者服務專線:+886-2-23756688 傳真:+886-2-23318496
地址:臺北市館前路28 號 7 樓 客服信箱
Copyright © 元照出版 All rights reserved. 版權所有,禁止轉貼節錄